Quick Summary
- MSC therapy targets myocardial repair, angiogenesis, and cardiac function improvement
- Suitable for heart failure, ischemic cardiomyopathy, angina, and post-MI recovery
- Intravenous and intracoronary delivery protocols for targeted cardiac regeneration
- All-inclusive packages from €7,500 at JCI-accredited cardiac center in Istanbul
- Published outcomes show improved ejection fraction and exercise tolerance
Conditions We Treat
Click any condition below to learn about our specific stem cell protocol, success rates, and treatment process.
Get Your Questions Answered
Six answers every patient needs before deciding on treatment for cardiovascular conditions.
Who may benefit?
Take the 2-minute candidacy self-check
Who is not suitable?
Honest exclusions and screening criteria
How is it delivered?
Routes of administration, stay, and protocol
Stem cells vs exosomes
Which therapy — or combined protocol — fits
Follow-up & aftercare
What happens after you fly home
Costs & travel
Package pricing and travel logistics
Cost Comparison: Turkey vs. Abroad
Turkey (Istanbul)
€7,500–€14,000
All-inclusive: hotel, transfers, labs
United States
$25,000–$80,000
Treatment only, excludes travel
United Kingdom
£18,000–£50,000
Treatment only, excludes travel
Save 60-80% on equivalent stem cell treatments compared to the US and UK.
Why Choose Istanbul for Cardiovascular Conditions Treatment?
GMP-Certified Laboratory
All stem cells processed in ISO-certified, GMP-compliant clean room facilities
JCI-Accredited Hospital
Treatments administered at internationally accredited hospitals with full emergency support
Improved Ejection Fraction in 72% of Patients
Based on published outcomes and patient-reported improvements across protocols
All-Inclusive Packages
Hotel, airport transfers, medical coordinator, post-treatment follow-up included
Frequently Asked Questions
International Patient Coordination
StemCell Longevita operates as an international patient coordination platform. We connect patients with licensed medical institutions that provide regenerative medicine applications following physician evaluation and applicable regulatory frameworks. All medical decisions and procedures are conducted exclusively by authorized healthcare professionals. StemCell Longevita does not directly provide medical treatment.
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as medical advice. Stem cell therapy is an evolving field, and outcomes may vary by individual. The treatments described on this site have not been fully evaluated or approved by the FDA or equivalent regulatory bodies in all jurisdictions.
The FDA has not approved stem cell applications for most conditions listed on this website. Results mentioned are based on clinical observations, published research, and patient-reported outcomes. Individual results may vary and no specific outcomes are assured for any individual patient.
Inclusion of scientific publications on this website does not imply regulatory approval, and does not imply any clinical outcome for an individual patient. Certain applications may be considered investigational depending on indication and jurisdiction.
Always consult with a qualified healthcare professional before making any medical decisions. Do not disregard professional medical advice or delay seeking treatment based on information found on this website.
Related clinical questions
Where this page sits in the wider picture.